Solid Tumor Unknown Status Phase 1 Trials for Capecitabine (DB01101)

Also known as: Cancer - Solid Tumors / Solid Tumour / Solid Tumours / Tumor, Solid / Solid Neoplasms / Solid tumour/cancer / Solid Cancers / Cancer: Solid Tumors / Neoplasms, Solid Tumor / Cancer, Solid Tumor / Tumors, Solid / Solid Tumor Cancer / Solid Tumors or Cancers / Solid Tumors / Solid Neoplasm / Cancer (Solid Tumors) / Solid Tumor Neoplasms / Solid Tumor Cancers / Solid Cancer / Neoplasm / Neoplasm (morphologic abnormality) / Neoplasms of unspecified behavior / Neoplasms NOS / Neoplasms NOS (disorder) / [M]Neoplasms NOS (morphologic abnormality) / Neoplasm (NOS) / Tumor / Neoplasm NOS / Tumour / Tumour NOS / Neoplasms / Tumour, NOS / Tumor NOS / Neoplasm, NOS / Tumor, NOS / Neoplasms benign, malignant and unspecified (incl cysts and polyps)

IndicationStatusPhase
DBCOND0030180 (Solid Tumor)Unknown Status1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06041035
A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid TumorsTreatment
NCT04802980
A Study of HB002.1T Plus Chemotherapy in Subjects With Solid TumorTreatment
NCT04522284
PRECISE CURATE.AI Pilot Clinical TrialTreatment
NCT03775525
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast CancerTreatment
NCT01315431
A Study of Tesetaxel Plus Capecitabine in Patients With Solid TumorsTreatment
NCT00726687
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid TumorsTreatment
NCT02435927
ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With LeucovorinTreatment